The Effect of Synthesis of Pegylated Nanoliposome Containing DNAi on Reduction of BCL-2 Gene Expression in DLCL2 Cell Line
Background and Objectives: Non-Hodgkin lymphoma is one of the common cancers that originates from lymphatic cells. The objective of this study was to assess the effectiveness of the DNAi containing pegylated nanoliposome (antisense drug) on decrease of BCL-2 gene expression. Methods: In this study, ...
Main Authors: | Farahnaz Boozari Saravani, Farzaneh Tafvizi, Mahmoud Reza Jaafari |
---|---|
Format: | Article |
Language: | fas |
Published: |
Qom University of Medical Sciences
2018-12-01
|
Series: | Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum |
Subjects: | |
Online Access: | http://journal.muq.ac.ir/browse.php?a_code=A-10-913-1&slc_lang=en&sid=1 |
Similar Items
-
Significance of Bcl-2 and Bcl-6 immunostaining in B-Non Hodgkin's lymphoma
by: Hanan Mohamed Mahmoud, et al.
Published: (2011-11-01) -
Unintended target effect of anti-BCL-2 DNAi
by: Ebrahim AS, et al.
Published: (2017-09-01) -
Evaluation of the Prognostic Importance of c-Myc and Bcl-2 Expressions and the Presence of Epstein-Barr Virus in Classical Hodgkin Lymphoma
by: Aydan KILIÇARSLAN, et al.
Published: (2018-09-01) -
Roles and Regulation of BCL-xL in Hematological Malignancies
by: Mario Morales-Martínez, et al.
Published: (2022-02-01) -
BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas
by: Magdalena Klanova, et al.
Published: (2020-04-01)